Sintx Technologies (SINT) Liabilities from Discontinued Operations (2017)
Sintx Technologies (SINT) posted quarterly Liabilities from Discontinued Operations of 2356000.0 for Q4 2017.
Sintx Technologies (SINT) Liabilities from Discontinued Operations (2017) Analysis & Trends
Sintx Technologies' Liabilities from Discontinued Operations history runs 1 years deep, the most recent figure standing at 2356000.0 for Q4 2017.
- In Q4 2017, Liabilities from Discontinued Operations changed N/A year-over-year to 2356000.0; the TTM figure through Dec 2017 stood at 2356000.0 (changed N/A YoY), while the FY2017 annual figure was 2356000.0, changed N/A from the prior year.
- Liabilities from Discontinued Operations for Q4 2017 stood at 2356000.0.
- The five-year high for Liabilities from Discontinued Operations was 2356000.0 in Q4 2017, with the low at 2356000.0 in Q4 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn |
| 10 | Sintx Technologies | 7.61 Mn | 7.61 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | 2.36 Mn |
| Dec 31, 2017 | 2.36 Mn |